Skip to main content
SpringerLink
Log in
Book cover

Tumeurs malignes rares pp 607–612Cite as

Tumeurs de la trompe de Fallope

  • Chapter

  • 81 Accesses

Résumé

Les cancers primitifs de la trompe sont des tumeurs rares, représentant entre 0,3 et 1,1% des tumeurs gynécologiques (1). L’incidence annuelle ajustée à l’âge entre 1998 et 2003 aux États-Unis était de 4,1 par million de femmes (2). Une étude finlandaise suggère que son incidence ajustée à l’âge augmente: 5,4 par million de femmes entre 1993 et 1997 contre 1,2 entre 1953 et 1957 (3). Ces données d’incidence peuvent avoir été faussées par les critères de définition qui attribuent à l’ovaire les formes avancées prenant «en masse la trompe et l’ovaire». Il est cependant 10 à 20 fois moins fréquent que le cancer de l’ovaire. Il s’agit dans la grande majorité des cas d’adénocarcinomes. Les autres types histologiques sont exceptionnels (tumeurs mixtes mullériennes, choriocarcinomes, sarcomes). Quatre-vingt pour cent des adénocarcinomes tubaires sont de forme papillaire séreuse (4).

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Nordin AJ (1994) Primary carcinoma of fallopian tube: a 20-year literature review. Obstet Gynecol Surv 49: 349–61

    Article  CAS  PubMed  Google Scholar 

  2. Stewart SL, Wike JM, Foster SL, Michaud F (2007) The incidence of primary fallopian tube cancer in the United States. Gynecol Oncol 107: 392–7

    Article  PubMed  Google Scholar 

  3. Riska A, Leminen A, Pukkala E (2003) Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953–97. Int J Cancer 104: 643–5

    Article  CAS  PubMed  Google Scholar 

  4. Baekelandt M, Jorunn Nesbakken A, Kristensen GB, et al. (2000) Carcinoma of the fallopian tube. Cancer 89: 2076–84

    Article  CAS  PubMed  Google Scholar 

  5. Pettersson F (1992) Staging rules for gestational trophoblastic tumors and fallopian tuba cancer. Acta Obstet Gynecol Scand 71: 224–5

    Article  CAS  PubMed  Google Scholar 

  6. Riska A, Sund R, Pukkala E, et al. (2007) Parity, tubal sterilization, hysterectomy and risk of primary fallopian tube carcinoma in Finland, 1975–2004. Int J Cancer 120: 1351–4

    Article  CAS  PubMed  Google Scholar 

  7. Jordan SJ, Green AC, Whiteman DC, et al. For the Australian Cancer Study Group (ovarian cancer) and the Australian Ovarian Cancer Study Group (2008) Serous ovarian, fallopian tube and primary peritoneal cancers: A comparative epidemiological analysis. Int J Cancer 122: 1598–603

    Google Scholar 

  8. Hankinson SE, Hunter DJ, Colditz GA, et al. (1993) Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA 270: 2813–18

    Article  CAS  PubMed  Google Scholar 

  9. Kjaer SK, Mellemkjaer L, Brinton LA, et al. (2004) Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65,000 sterilized women. Int J Epidemiol 33: 596–602

    Article  PubMed  Google Scholar 

  10. Irwin KL, Weiss NS, Lee NC, Peterson HB (1991) Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer. Am J Epidemiol 134: 362–9

    CAS  PubMed  Google Scholar 

  11. Gungor T, Keskin HL, Zergeroglu S, et al. (2003) Tuberculous salpingitis in two of five primary fallopian tube carcinoma Journal of Obstetrics and Gynaecology 23: 193–5

    Article  CAS  PubMed  Google Scholar 

  12. Finch A, Beiner M, Lubinski J, et al. (2006) Hereditary Ovarian Cancer Clinical Study Group. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA 296: 185–92

    Article  CAS  PubMed  Google Scholar 

  13. Laki F, Kirova YM, This P, et al. for the IC-BOCRSG ICBOCRSG: Institut Curie — Breast Ovary Cancer Risk Study Group (2007) Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation. Cancer 109: 1784–90

    Article  CAS  PubMed  Google Scholar 

  14. Delaloge S, Morice P, Chompret A, Lhommé C (2000). Prophylactic surgery: oophorectomy or adnexectomy? J Clin Oncol 18: 3454–3455

    CAS  PubMed  Google Scholar 

  15. Chung TK, Cheung TH, To KF, et al. (2000) Over-expression of p53 and HER-2/neu and c-myc in primary fallopian tube carcinoma. Gynecol Obstet Invest 49: 47–51

    Article  CAS  PubMed  Google Scholar 

  16. Ajithkumar TV, Minimole AL, John MM, et al. (2005) Primary fallopian tube carcinoma. Obstet Gynecol Surv 60: 247–52

    Article  CAS  PubMed  Google Scholar 

  17. Kol S, Gal D, Friedman M, et al. (1998) Preoperative diagnosis of primary fallopian tube carcinoma. Gynecol Oncol 68: 29–34

    Article  Google Scholar 

  18. Kurjak A, Kupesic S, Sparac V, et al. (2000) Three-dimensional ultrasonographic and power Doppler characterization of ovarian lesions. Ultrasound Obstet Gynecol 16: 365–71

    Article  CAS  PubMed  Google Scholar 

  19. Kawakami S, Togashi K, Kimura I, et al. (1993) Primary malignant tumor of the fallopian tube: appearance at CT and MR imaging. Radiology 186: 503–8

    CAS  PubMed  Google Scholar 

  20. Hefler LA, Rosen AC, Graf AH, et al. (2000) The clinical value of serum concentrations of cancer antigen in patients with primary fallopian tube carcinoma: a multicenter study. Cancer 89: 1555–60

    Article  CAS  PubMed  Google Scholar 

  21. Alvarado-Cabrero I, Young RH, Vamvakas EC, Scully RE (1999) Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors. Gynecol Oncol 72: 367–79

    Article  CAS  PubMed  Google Scholar 

  22. Zheng W, Wolf S, Kramer EE, et al. (1996) Borderline papillary serous tumour of the fallopian tube. Am J Surg Pathol 20: 30–5

    Article  CAS  PubMed  Google Scholar 

  23. Sedlis A (1978) Carcinoma of the fallopian tube. Surg Clin North Am 58: 121–9

    CAS  PubMed  Google Scholar 

  24. Deffieux X, Morice P, Thoury A, et al. (2005) Pelvi and para aortic lymphatic involvement in tubal carcinoma: topography and surgical implications. Gynecol Obstet Fertil 33: 23–8

    Article  CAS  PubMed  Google Scholar 

  25. Benedet JL, Miller DM (1991) Tumors of the Fallopian Tube: Clinical Features, Staging and Management. In Coppleston M (ed): Gynecological Oncology. Edimburgh, Churchill Livingstone, 2nd ed, vol 2, p. 853–60

    Google Scholar 

  26. Singhal P, Odunsi K, Rodabaugh K, et al. (2006) Primary fallopian tube carcinoma: a retrospective clinicopathologic study. Eur J Gynaecol Oncol 27: 16–8

    CAS  PubMed  Google Scholar 

  27. Pectasides D, Pectasides E, Economopoulos T (2006) Fallopian Tube Carcinoma: A Review. Oncologist 11: 902–12

    Article  PubMed  Google Scholar 

  28. Vaughan MM, Evans BD, Baranyai J, et al. (1998) Survival of patients with primary fallopian tube carcinoma. Int J Gynecol Cancer 8: 16–22

    Article  PubMed  Google Scholar 

  29. Rosen AC, Klein M, Hafner E, et al. (1999) Management and prognosis of primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Gynecol Oncol 81: 150–9

    Google Scholar 

  30. Peters WA 3rd, Andersen WA, Hopkins MP, et al. (1988) Prognostic features of carcinoma of the fallopian tube. Obstet Gynecol 71: 757–62

    PubMed  Google Scholar 

  31. McMurray E, Jacobs AJ, Perez CA, et al. (1986) Carcinoma of the fallopian tube. Management and sites of failure. Cancer 58: 2070–5

    Article  CAS  PubMed  Google Scholar 

  32. Baekelandt M, Kockx M, Wesling F, et al. (1993) Primary adenocarcinoma of the fallopian tube. Review of the literature. Int J Gynecol Cancer 3: 65–71

    Article  PubMed  Google Scholar 

  33. Gaducci A, Landoni F, Sartori E, et al. (2001) Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a CTF study. Gynecol Oncol 81: 150–9

    Article  Google Scholar 

  34. Markman M, Kennedy A, Webster K, et al. (2001) Combination chemotherapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum. J Clin Oncol 19: 1901–5

    CAS  PubMed  Google Scholar 

  35. Bancher-Todesca D, Rosen A, Graf A, et al. (1999) Prognostic significance of tumor angiogenesis in primary fallopian tube carcinoma. Cancer Lett 141: 179–86

    Article  CAS  PubMed  Google Scholar 

  36. Arora N, Tewari D, Cowan C, et al. (2008) Bevacizumab demonstrates activity in advanced refractory fallopian tube carcinoma. Int J Gynecol cancer 18: 369–72

    Article  CAS  PubMed  Google Scholar 

  37. Cannistra SA, Matulonis UA, Penson RT, et al. (2007). Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer. J Clin Oncol 25: 5180–6

    Article  CAS  PubMed  Google Scholar 

  38. Burger RA, Sill MW, Monk BJ, et al. (2007) Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study. J Clin Oncol 25: 5165–71

    Article  CAS  PubMed  Google Scholar 

  39. Sabbatini P, Dupont J, Aghajanian C, et al. (2006) Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer. Clin Cancer Res 12: 5503–10

    Article  CAS  PubMed  Google Scholar 

  40. Buller RE, Runnebaum IB, Karlan BY, et al. (2002) A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer. Cancer Gene Ther 9: 553–66

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unité de biochimie hormonale Assistance publique — Hôpitaux de Paris, Hôpital Saint-Louis, 1, rue Claude-Vellefaux, 75 010, Paris

    Philippe Boudou

  2. Département de chirurgie Comité de gynécologie, Institut Gustave-Roussy, 39-42, rue Camille Desmoulins, 94800, Villejuif

    Philippe Morice

  3. Département d’anatomie pathologique Comité de gynécologie, Institut Gustave-Roussy, 39-42, rue Camille Desmoulins, 94800, Villejuif

    Pierre Duvillard

  4. Service de gynécologie Département de médecine, Institut Gustave-Roussy, 39-42, rue Camille-Desmoulins, 94800, Villejuif

    Patricia Pautier

Authors
  1. Philippe Boudou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philippe Morice
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pierre Duvillard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patricia Pautier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Boudou, P., Morice, P., Duvillard, P., Pautier, P. (2010). Tumeurs de la trompe de Fallope. In: Tumeurs malignes rares. Springer, Paris. https://doi.org/10.1007/978-2-287-72070-3_98

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-72070-3_98

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-72069-7

  • Online ISBN: 978-2-287-72070-3

Publish with us

Policies and ethics

Search

Navigation